A+ Stock Grade Summary:
| VALUE: |
|
|
| GROWTH: |
|
|
| MOMENTUM: |
|
|
| EPS REVISIONS: |
|
|
| QUALITY: |
|
|
Jenna Brashear
| Share Statistics | MRKR | Industry Median |
Percentile (All Stocks) |
|
| Market Cap (Mil) | $20.2 | $286.3 | 10% |
|
| Shares Out (Mil) | 19.3 | 54.2 | 29% |
|
| Institutional Ownership | 70.2% | 92.8% | 43% |
|
| Float (Mil) | 13.7 | 39.7 | 23% |
|
| Beta | na | 0.94 | na |
|
| Avg Daily Volume (000s) | 69 | 534 | 31% |
|
| Price Change (52-week) |
7.1% | 58.7% | 51% |
|
| Growth | MRKR | Industry Median |
Percentile (All Stocks) |
|
| Sales (5yr) | 47.6% | 13.6% | 95% |
|
| Net Income (5yr) | 15.7% | (10.1%) | 65% |
|
| EPS (5yr) | 33.5% | 16.0% | 84 |
|
| Dividends (5yr) | 0.0% | 0.0% | 0% |
|
| Cash Flow (5yr) | 50.7% | (15.6%) | 93% |
|
| Estimates | Qtrly | Current Fiscal Year |
Next Fiscal Year |
|
| # of Estimates | 2 | 2 | 2 | |
| Current EPS | ($0.140) | ($0.565) | ($0.530) | |
| Month Ago EPS | ($0.185) | ($0.690) | ($0.755) | |
| # Rev Up | 0 | 0 | 0 | |
| # Rev Down | 0 | 1 | 1 | |
| Three Months Ago EPS | ($0.120) | ($0.550) | ($0.170) | |
| Year/Year Chg | 47.4% | (28.8%) | (109.4%) | |
| Financials | MRKR | Industry Median |
Percentile (All Stocks) |
|
| Sales (TTM) (Mil) | $3 | $37 | 4% |
|
| Net Income (TTM) (Mil) | ($9) | ($43) | 30% |
|
| EPS (TTM) | ($0.466) | ($1.400) | 28% |
|
| Operating Cash Flow (TTM) (Mil) | ($10) | ($31) | 20% |
|
| Net Cash Flow (TTM) (Mil) | na | $2 | na |
|
| Long-Term Debt (Q1) (Mil) | $0 | $4 | 0% |
|
| Enterprise Value (Q1) (Mil) | na | $160 | na |
|
| Valuation | MRKR | Industry Median |
Percentile (All Stocks) |
|
| P/B | 1.66 | 2.77 | 43% |
|
| P/E | na | 19.1 | na |
|
| Dividend Yield | na | 0.0% | na |
|
| PEG (5yr hist) | na | 1.0 | na |
|
| Ratios | MRKR | Industry Median |
Percentile (All Stocks) |
|
| Gross Margin | (67.1%) | 64.2% | 2% |
|
| Net Margin | (324.2%) | (75.9%) | 3% |
|
| ROA | (59.3%) | (47.3%) | 10% |
|
| ROE | (76.9%) | (55.0%) | 11% |
|
| Liabilities to Assets | 16.6% | 29.6% | 10% |
|
| F-Score | 2 | 2 | 7% |
|
Marker Therapeutics, Inc. did not pass any screens on 8/20/2026.
Price and market data provided by QuoteMedia and delayed a minimum of 15 minutes unless otherwise indicated. Fundamental data provided by AAII's Stock Investor Pro and S&P Global Market Intelligence and are updated through the previous trading day.
Ⓒ 2026 American Association of Individual Investors
